Anti-Osteoporotic Treatment Efficacy in Patients with Psoriatic Arthritis – description of a tertiary center
Psoriatic arthritis (PsA) is a long-term inflammatory disease that affects the joints and can also impact overall bone health. Ongoing inflammation may weaken bones over time, increasing the risk of osteoporosis (OP) and fractures. While treatments are available to prevent bone loss, there is limited information regarding the effectiveness of these therapies in PsA patients. Understanding the effectiveness of anti-osteoporotic treatments in this population is important to improve fracture prevention and long-term outcomes.


